Dr. Michael Kaplan, MD

Dr. Kaplan practices at Mount Sinai West in New York, New York, part of Mount Sinai Health System.

Dr. Kaplan's NPI, 1073925913, was assigned on May 27, 2014. Dr. Kaplan holds New York license 288842.

Dr. Kaplan's primary practice is Mount Sinai West, at 1000 Tenth Avenue, New York, NY 10019 in New York County. The practice phone is (212) 523-4000.

Dr. Kaplan's primary practice is Mount Sinai West in New York, New York, part of Mount Sinai Health System. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Kaplan to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kaplan practices, 3 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Kaplan's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Kaplan is licensed in New York.

CMS data shows 415 Medicare services from Dr. Kaplan across 4 procedure codes in 2024, for 141 Medicare patients. Medicare paid $20,127 for them.

CMS counts 141 Medicare patients who saw Dr. Kaplan in 2024. The largest group is 75 to 84, with 62 patients. 75% of them have arthritis, and 75% have high blood pressure. 24% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kaplan's median patient age at 58, with 74% women.

In 2024, Dr. Kaplan wrote 2,045 Medicare Part D claims for 261 patients. 96% of them were for generic drugs. CMS names the drug for 1,880 of them, across 31 drugs with 11 or more claims each, at $157,173 in total drug cost. In 2023, CMS named 2,083 claims across 32 drugs.

Dr. Kaplan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kaplan as offering telehealth.

Dmand AI links 27 papers to Dr. Kaplan, published from 2016 to 2024. 2019 was the busiest year, with 5. The most frequent topics are Head and Neck Neoplasms, Panitumumab and Squamous Cell Carcinoma of Head and Neck. Dr. Kaplan has published most often in Am J Manag Care. Dr. Kaplan's most frequent co-authors are Michael Jay Kaplan, MD, Vasu Divi, MD and Eben L. Rosenthal, MD.

CMS Open Payments shows 25 general payments to Dr. Kaplan from 10 drug and device companies from 2020 to 2025. Consulting fees make up the largest share, 75% of the total. Tonix Pharmaceuticals, Inc. paid the most, $6,293.